CoChat

AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression

Open access
Marcondes‐de‐Castro, Ilitch Aquino, Reis‐Barbosa, Pedro Henrique, Marinho, Thatiany Souza, Aguila, Marcia Barbosa, Mandarim‐de‐Lacerda, Carlos Alberto · 2023 · Journal of Gastroenterology and Hepatology
Cited by 102

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Obesity is related to several organs, but the liver is particularly affected. Adenosine monophosphate‐activated protein kinase (AMPK) is a cellular energy sensor and regulator of liver lipid dysfunction and glucose metabolism. The mechanistic target of rapamycin (mTOR) is a protein kinase regulating cell growth, survival, metabolism, and immunity. Together, these pathways are involved in obesity, insulin resistance, non‐alcoholic fatty liver disease (NAFLD) and its progression, and autophagy. During energy demand, liver kinase B (LKB) phosphorylation helps activate the AMPK/mTOR pathways. Likewise, the protein forkhead box O family (FOXO) negatively regulates adipogenesis by binding to the promoter sites of peroxisome proliferator‐activated receptor‐gamma coactivator 1‐alpha, initiating adipogenesis. In addition, acetyl‐CoA carboxylase, which regulates de novo lipogenesis, is linked to LKB and FOXO in developing NAFLD. The kinase complex, consisting of Unc‐51‐like autophagy‐activating kinase 1 or 2 (ULK1, ULK2) by stimulating autophagy, and eliminating fat droplets in NAFLD, is regulated by mTORC1 and negatively regulated by AMPK that suppresses liver lipogenesis and increases fatty acid oxidation. Also, ULK1 is essential for initiating phagophore formation, establishing macrophagy, and generating autophagosomes. The selective breakdown of lipid droplets through macroautophagy, or macrolipophagy, occurs on a cellular energy level using free fatty acids. In addition, mTORC1 promotes lipogenesis by activating sterol regulatory element‐binding protein. Finding new components and novel regulatory modes in signaling is significant for a better understanding of the AMPK/mTOR pathways, potentially facilitating the development of future diagnostic and therapeutic strategies for NAFLD and its progression to non‐alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jgh.16272

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 63

  1. 10.1002/hep.31420 · DOI · Paper page
  2. 10.1097/hc9.0000000000000112 · DOI
  3. 10.1001/jama.2015.5370 · DOI · Paper page
  4. 10.1146/annurev‐nutr‐062220‐105200 · DOI · Paper page
  5. 10.1016/j.plefa.2018.11.005 · DOI
  6. 10.1038/nrdp.2015.80 · DOI · Paper page
  7. 10.1590/1414‐431X2021e11391 · DOI
  8. 10.1038/s41591‐018‐0104‐9 · DOI · Paper page
  9. 10.2174/1381612811319290006 · DOI · Paper page
  10. 10.1371/journal.pone.0146675 · DOI
  11. 10.1097/MEG.0000000000001235 · DOI
  12. 10.1007/s00428‐011‐1147‐1 · DOI
  13. 10.4067/s0717‐95022017000401482 · DOI
  14. 10.1007/978‐1‐60327‐345‐9_17 · doi:10.1007/978-1-60327-345-9_17
  15. 10.1016/j.livres.2020.02.004 · DOI
  16. 10.1016/j.clinre.2022.101922 · DOI
  17. 10.1146/annurev‐pharmtox‐010611‐134537 · DOI · Paper page
  18. 10.1111/j.1432‐1033.1991.tb16172.x · DOI · Paper page
  19. 10.1038/sj.onc.1204091 · DOI · Paper page
  20. 10.1155/2021/6655599 · DOI
  21. 10.1111/1750‐3841.14723 · DOI
  22. 10.1021/acs.jafc.0c07342 · DOI
  23. 10.1016/j.bbagrm.2016.03.002 · DOI · Paper page
  24. 10.3748/wjg.v27.i25.3837 · DOI · Paper page
  25. 10.1016/j.micpath.2018.03.021 · DOI
  26. 10.1016/j.canlet.2017.06.029 · DOI
  27. 10.1002/path.2697 · DOI · Paper page
  28. 10.1371/journal.pone.0165417 · DOI
  29. 10.1016/j.celrep.2017.04.042 · DOI · Paper page
  30. 10.1007/s00109‐021‐02117‐8 · DOI
  31. 10.1371/journal.pbio.3001522 · DOI
  32. 10.1152/physrev.00026.2020 · DOI · Paper page
  33. 10.1016/s0960‐9822(02)01077‐1 · DOI · Paper page
  34. 10.1152/ajpendo.00225.2016 · DOI · Paper page
  35. 10.1016/j.lfs.2021.119424 · DOI
  36. 10.1016/j.cellsig.2013.06.007 · DOI · Paper page
  37. 10.3390/ijms21062061 · DOI · Paper page
  38. 10.2337/db20‐0619 · DOI
  39. 10.1002/hep.32066 · DOI · Paper page
  40. 10.3390/cells9040837 · DOI · Paper page
  41. 10.3389/fcell.2021.655731 · DOI · Paper page
  42. 10.1016/j.celrep.2019.07.084 · DOI · Paper page
  43. 10.1007/s13238‐017‐0409‐3 · DOI · Paper page
  44. 10.1038/s42255‐021‐00440‐5 · DOI
  45. 10.1016/j.mam.2016.11.008 · DOI
  46. 10.1038/ncomms11365 · DOI · Paper page
  47. 10.1016/j.molcel.2017.05.030 · DOI · Paper page
  48. 10.1152/ajpendo.00660.2011 · DOI · Paper page
  49. 10.18632/oncotarget.3044 · DOI
  50. 10.1080/15384101.2016.1151581 · DOI · Paper page
  51. 10.1016/j.mam.2021.100973 · DOI · Paper page
  52. 10.1152/ajpgi.00451.2010 · DOI
  53. 10.3350/cmh.2020.0169 · DOI · Paper page
  54. 10.1080/15548627.2021.1895658 · DOI · Paper page
  55. 10.1002/jcp.29727 · DOI · Paper page
  56. 10.1083/jcb.201711002 · DOI · Paper page
  57. 10.4103/1673‐5374.340406 · DOI
  58. 10.1016/j.biochi.2021.11.008 · DOI · Paper page
  59. 10.1016/j.intimp.2016.11.015 · DOI
  60. 10.1007/s12011‐022‐03438‐6 · DOI
  61. 10.1248/bpb.b17‐00724 · DOI · Paper page
  62. 10.1038/s41366‐021‐00955‐7 · DOI
  63. 10.1158/0008‐5472.CAN‐21‐1259 · DOI

Cited by

See all 102

Metadata

Authors
Marcondes‐de‐Castro, I. A., Reis‐Barbosa, P. H., Marinho, T. S., Aguila, M. B., & Mandarim‐de‐Lacerda, C. A.
Venue
Journal of Gastroenterology and Hepatology
Publisher
Wiley
Published
2023-07-12
Volume
38
Issue
11
Pages
1868-1876
ISSN
  • 0815-9319 (ISSN-L)
  • 1440-1746
OpenAlex
W4384120487
Cited by
102
References
12
FWCI
17.06
Type
journal article
Language
en
Open access
bronze
Funders
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E‐26/200.796/2021, E‐26/200.936/2021)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (305993/2021‐6)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance code 001)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression. https://app.cochat.ai/papers/10.1111/jgh.16272
The paper
Marcondes‐de‐Castro, I. A., Reis‐Barbosa, P. H., Marinho, T. S., Aguila, M. B., & Mandarim‐de‐Lacerda, C. A. (2023). AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16272

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.